STAT3 and liver cancer: In the current study, FPHPE was found to inhibit the growth of HCC by reducing the phosphorylation of JAK2 and STAT3 and preventing STAT3 from going into the nucleus, suggesting that FPHPE alleviated the inflammatory signaling of liver cancer by targeting the JAK2/STAT3 pathway.